(a)Specifications. Each milliliter of sterile aqueous solution contains 3 milligrams of carfentanil citrate.
(b)Sponsor. See No. 053923 in § 510.600(c) of this chapter.
(c)Conditions of use—
(1)Amount. 5 to 20 micrograms per kilogram (.005 to .020 milligram per kilogram) of body weight.
(2)Indications for use. For immobilizing free ranging and confined members of the family Cervidae (deer, elk, and moose).
(3)Limitations. Inject into large muscle of neck, shoulder, back, or hindquarter. Avoid intrathoracic, intra-abdominal, or subcutaneous injection. To reverse effect, use 7 milligrams of diprenorphine for each milligram of carefentanil citrate, given intravenously or one-half intravenously and one-half intramuscularly or subcutaneously. Do not use in domestic animals intended for food. Do not use 30 days before or during hunting season. Do not use in animals that display clinical signs of severe cardiovascular or respiratory disease. Available data are inadequate to recommend use in pregnant animals. Avoid use during breeding season. Federal law restricts this drug to use by or on the order of a licensed veterinarian. The licensed veterinarian shall be a veterinarian engaged in zoo and exotic animal practice, wildlife management programs, or research.
[53 FR 40057, Oct. 13, 1988. Redesignated at 73 FR 29685, May 22, 2008]
Title 21 published on 2014-04-01
The following are only the Rules published in the Federal Register after the published date of Title 21.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.